| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Coronavirus disease-19 mortality among solid organ transplant recipients in the United States during June and December 2020: Comparison of Organ Procurement and Transplantation Network and National Death Index data
|
Volesky-Avellaneda, Karena D.
|
|
|
23 |
5 |
p. 686-687
|
article
|
| 2 |
Corrigendum to ‘Assessment of long-term outcomes post living liver donation highlights the importance of scientific integrity when presenting transplant registry data’ [American Journal of Transplantation. Volume 22, Issue 6, March 2023, Pages 1519-1522]
|
Emamaullee, Juliet
|
|
|
23 |
5 |
p. 695
|
article
|
| 3 |
Corrigendum to “Islet allografts expressing a PD-L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression” [American Journal of Transplantation (2022) 2571–2585]
|
Paul, Pradyut K.
|
|
|
23 |
5 |
p. 693
|
article
|
| 4 |
Corrigendum to ‘Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report’ [American Journal of Transplantation 23 (2023) 133–149]
|
Tambur, Anat R.
|
|
|
23 |
5 |
p. 694
|
article
|
| 5 |
Deceased organ donor interventions: Difficult but important research New findings support the use of machine perfusion following kidney transplantation from a deceased donor
|
Pullen, Lara C.
|
|
|
23 |
5 |
p. 591-592
|
article
|
| 6 |
Early allograft dysfunction in a pediatric liver allograft with an occult pathogenic mutation in the urea cycle
|
Rezvani, Milad
|
|
|
23 |
5 |
p. 673-675
|
article
|
| 7 |
Engineering pancreatic islets with a novel form of thrombomodulin protein to overcome early graft loss triggered by instant blood-mediated inflammatory reaction
|
Turan, Ali
|
|
|
23 |
5 |
p. 619-628
|
article
|
| 8 |
Genetic evaluation of living kidney donor candidates: A review and recommendations for best practices
|
Thomas, Christie P.
|
|
|
23 |
5 |
p. 597-607
|
article
|
| 9 |
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients
|
Kemlin, Delphine
|
|
|
23 |
5 |
p. 649-658
|
article
|
| 10 |
Impacts of removing race from the calculation of the kidney donor profile index
|
Miller, Jonathan
|
|
|
23 |
5 |
p. 636-641
|
article
|
| 11 |
Incidence of and risk factors for influenza-associated hospital encounters in pediatric solid organ transplant recipients
|
Haddadin, Zaid
|
|
|
23 |
5 |
p. 659-665
|
article
|
| 12 |
Increasing liver organ acquisition fees and the risk of a tragedy of the commons
|
Wall, Anji
|
|
|
23 |
5 |
p. 689-690
|
article
|
| 13 |
Liver Transplantation for Fulminant Hepatic Failure in a Young Woman
|
Fernández-Yunquera, Ainhoa
|
|
|
23 |
5 |
p. 682-685
|
article
|
| 14 |
Mutations in latent membrane protein 1 of Epstein-Barr virus are associated with increased risk of posttransplant lymphoproliferative disorder in children
|
Martinez, Olivia M.
|
|
|
23 |
5 |
p. 611-618
|
article
|
| 15 |
Reply to American Society of Transplant Surgeons Recommendations on Best Practices in Donation After Circulatory Death Organ Procurement “Questions on Best Practices in DCD”
|
Peled, Harry
|
|
|
23 |
5 |
p. 688
|
article
|
| 16 |
Robotic kidney transplantation from deceased donors: A single-center experience
|
Spaggiari, Mario
|
|
|
23 |
5 |
p. 642-648
|
article
|
| 17 |
T cells: Surviving a decade of cell proliferation in vivo
|
Chen, Wenhao
|
|
|
23 |
5 |
p. 593-594
|
article
|
| 18 |
The association of donor hepatitis C virus infection with 3-year kidney transplant outcomes in the era of direct-acting antiviral medications
|
Sutcliffe, Siobhan
|
|
|
23 |
5 |
p. 629-635
|
article
|
| 19 |
Time to discard the term “discard”
|
Hart, Allyson
|
|
|
23 |
5 |
p. 608-610
|
article
|
| 20 |
Time to reconsider the role of donor hepatitis C status in the Kidney Donor Risk Index
|
Potluri, Vishnu
|
|
|
23 |
5 |
p. 595-596
|
article
|
| 21 |
Trends in the survival benefit of repeat kidney transplantation over the past 3 decades
|
Sandal, Shaifali
|
|
|
23 |
5 |
p. 666-672
|
article
|
| 22 |
Use of tecovirimat for the treatment of mpox infection in a kidney transplant recipient
|
Caillard, Sophie
|
|
|
23 |
5 |
p. 691-692
|
article
|
| 23 |
Vital Signs: Health Disparities in Hemodialysis-Associated Staphylococcus aureus Bloodstream Infections — United States, 2017–2020
|
Rha, Brian
|
|
|
23 |
5 |
p. 676-681
|
article
|
Journal description